
OpinionMay 18, 2021
Why Monoclonal Antibody COVID Therapies Have Not Lived Up to Expectations
The drugs used to treat Donald Trump have not been widely administered to other patients, but they still have a role to play
Carlos del Rio is a physician who is a distinguished professor of medicine in the division of infectious diseases at Emory University School of Medicine and executive associate dean for Emory in the Grady Health System. He is also professor of global health in the Department of Global Health and professor of epidemiology at the Rollins School of Public Health.

Why Monoclonal Antibody COVID Therapies Have Not Lived Up to Expectations
The drugs used to treat Donald Trump have not been widely administered to other patients, but they still have a role to play